Liu Zihao, Zhang Wen, Zhang Xin, Wang Shijia, Xia Zhiwen, Guo Xiaoyan, Zhao Yu, Wang Pu, Wang Xiu-Hong
Laboratory for Biomedical Photonics, Beijing University of Technology, Beijing100124, China.
Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.
Anal Chem. 2023 Jan 17;95(2):1095-1105. doi: 10.1021/acs.analchem.2c03794. Epub 2023 Jan 4.
Exosome-based liquid biopsies highlight potential utility in diagnosis and determining the prognosis of patients with cancer and other diseases. However, the existing techniques are severely limited for practical applications due to the complications of high cost, low sensitivity, tedious procedures, and large sample consumption. Herein, we report a microstructured optical fiber sensor for fast, sensitive, and accurate quantification of exosomes in blood samples of breast cancer patients. Numerical simulations are applied to demonstrate that hollow-core microstructured antiresonant fibers (HARFs) can stringently confine light in the fiber core, ensuring strong light-matter interaction and thus maximumly amplifying the signal. Taking this advantage, a AuNPs-dsDNA assembly containing gold nanoparticles, a recognizing DNA aptamer, and a fluorescent reporter DNA sequence is fabricated followed by immobilization on the fiber wall to form a AuNPs-dsDNA-HARF sensor. Cancer-derived exosomes can be recognized and captured in the fiber channel and generate dose-dependent fluorescent signals for quantification. The microfiber sensor demonstrates enhanced sensitivity and specificity, enabling the detection of single digits of exosome particles at the nanoliter sample level. In addition, by tracking exosome phenotypic changes, the proposed fiber sensor can facilitate precise drug treatment monitoring. This work provides a robust platform for exosome-based biopsy for cancer diagnosis and prediction of therapeutic outcomes.
基于外泌体的液体活检在癌症和其他疾病患者的诊断及预后判断中显示出潜在效用。然而,由于存在成本高、灵敏度低、操作繁琐以及样本消耗量大等问题,现有技术在实际应用中受到严重限制。在此,我们报道了一种用于快速、灵敏且准确地定量乳腺癌患者血液样本中外泌体的微结构光纤传感器。通过数值模拟表明,空心微结构反谐振光纤(HARF)能够将光严格限制在光纤芯中,确保强光与物质的相互作用,从而最大程度地放大信号。利用这一优势,制备了一种包含金纳米颗粒、识别DNA适配体和荧光报告DNA序列的AuNPs-dsDNA组装体,随后将其固定在光纤壁上,形成AuNPs-dsDNA-HARF传感器。癌症来源的外泌体能够在光纤通道中被识别和捕获,并产生剂量依赖性荧光信号用于定量分析。该微纤维传感器展现出更高的灵敏度和特异性,能够在纳升样本水平检测到个位数的外泌体颗粒。此外,通过追踪外泌体表型变化,所提出的光纤传感器有助于精确监测药物治疗效果。这项工作为基于外泌体的癌症诊断活检及治疗结果预测提供了一个强大的平台。